SKU: 88867085907

Duhaney Clinical Trials Investment Dashboard

Sale price$5400.00 Regular price$6000.00
Save 10%

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Jul 13 - Jul 18

Promo Codes Available:

For Your Every Summer RSVP, with Code: SUMMER15

Description

Duhaney Clinical Trials Investment DashboardDuhaney Real Estate Deal Command Center Full Ecosystem Duhaney Clinical Trials Investment Dashboard Your Insider Guide to Drug Success & ROI Starting Price: $1500. 00 USD The Truth About Clinical Trials Nobody Tells You If youve ever tried to predict which drug will win FDA approval, or which trial will attract the next big investment, you already know the truth **the data is scattered, outdated, and full of noise**. Most clinical reports tell you

Duhaney Real Estate Deal Command Center – Full Ecosystem

Duhaney Clinical Trials Investment Dashboard – Your Insider Guide to Drug Success & ROI

Starting Price: $1500.00 USD

The Truth About Clinical Trials Nobody Tells You

If you’ve ever tried to predict which drug will win FDA approval, or which trial will attract the next big investment, you already know the truth — **the data is scattered, outdated, and full of noise**.

Most clinical reports tell you **what happened**, but they never tell you **what it really means for your investment, your startup, or your next move**.

---

Let’s Deframe That Entire Process

Why guess when you could have a **real-time dashboard** that connects the dots between:

  • ✅ Which sponsors dominate in each therapeutic area
  • ✅ The **real cost per patient** by condition and phase
  • ✅ The historical **ROI for every major trial category**
  • ✅ Which drugs have **the highest probability of approval**
  • ✅ And exactly which conditions are pulling the most investment dollars right now

---

Now Let’s Reframe — What You’re Actually Getting

The **Duhaney Clinical Trials Investment Dashboard** isn’t a static report — it’s your **decision engine**. Every time you need to answer questions like:

  • 💰 Which drug is about to make investors rich?
  • 📊 Which sponsor should my startup partner with?
  • ⚕️ Which condition is about to have a blockbuster approval?
  • 📈 What’s the **per-patient cost vs revenue potential** for each drug?
  • 🔍 Which trials are actually worth tracking — and which are just noise?

…you load the dashboard and the answers are right there.

---

What’s Inside Your Personalized Dashboard

✅ Pre-loaded with the **top 50 therapeutic areas** (Sickle Cell, Oncology, Rare Diseases, and more) ✅ Full **financial modeling** — cost per patient, projected revenue per patient, and calculated ROI ✅ FDA study phases & statuses — see which trials are closest to approval ✅ Sponsor and CRO performance tracking — know who delivers and who burns money ✅ Real-time NCT Number cross-referencing — no more disconnected data

---

Why This Dashboard is Different

✅ **Built directly from FDA clinicaltrials.gov data** — no second-hand garbage ✅ **Includes historical AND current data** — so you can track trends, not just snapshots ✅ **Custom-built to your needs** — you tell us your focus (condition, phase, region, sponsor type) and we personalize the dashboard to fit you.

---

Call Before Purchase – Here’s Why

Because this isn’t a one-size-fits-all product. Every investor, startup, or pharma exec has a unique focus — oncology vs rare disease, early-stage vs late-stage trials, US vs global markets.

That’s why you must call me directly before purchase, so I can personally customize your dashboard to fit your strategy.

Contact Rohan Duhaney
Phone: (856) 522-3601
Email: [email protected]

---

Future Price Increases

The current price of **$1500.00 USD** reflects the early release version. As new data sources, advanced modeling, and predictive AI get added, the price will increase significantly.

**Secure your personalized dashboard now at today’s rate — and lock in free updates for the first 60 days.**

---

Ready to See What Real Clinical Intelligence Feels Like?

Call me today — and let’s build your **custom intelligence engine** so you can make smarter, faster decisions in clinical development and biotech investing.

Rohan Duhaney

Phone: 856-522-3601
Email: [email protected]
Website: smartduhaney.com

 

PROOF OF WORK

 


        Healthcare Solutions Dashboard Output
        Brought to you by Rohan Duhaney
        Contact: 856-522-3601 | Email: [email protected] | Website: smartduhaney.com
        ----------------------------------------------------------------------
        Condition: Sickle Cell Disease
        Cure: DRUG: ATG|DRUG: fludarabine|DRUG: cyclophosphamide|RADIATION: Total body irradiation|PROCEDURE: Stem cell infusion|DRUG: Sirolimus|DRUG: mycophenolate mofetil

        For Investors only investing in a study:
        Financial Forecast:
        • Total Cost per Patient: $250,000.00
        • Total Revenue per Patient: $2,100,000.00
        • ROI: 740.0%

        NCT Number: NCT03121001
        Study Phase: PHASE2
        Study Status: RECRUITING

        Additional Insights:
        • Devices/Interventions: No device listed
        • Enrollment: 50
        • Sponsor: University of Illinois at Chicago
        ----------------------------------------------------------------------
        

        Healthcare Solutions Dashboard Output
        Brought to you by Rohan Duhaney
        Contact: 856-522-3601 | Email: [email protected] | Website: smartduhaney.com
        ----------------------------------------------------------------------
        Condition: HbS Disease|Hemoglobin S Disease|Sickle Cell Anemia|Sickle Cell Disorders|Sickling Disorder Due to Hemoglobin S|Sickle Cell Disease
        Cure: OTHER: TCRα/β+ and CD19+ depleted haploidentical stem cell transplantation|OTHER: Matched sibling donor transplantation

        For Investors only investing in a study:
        Financial Forecast:
        • Total Cost per Patient: $1,060,000.00
        • Total Revenue per Patient: $8,904,000.00
        • ROI: 740.0%

        NCT Number: NCT04201210
        Study Phase: PHASE2
        Study Status: RECRUITING

        Additional Insights:
        • Devices/Interventions: No device listed
        • Enrollment: 212
        • Sponsor: University of Regensburg
        ----------------------------------------------------------------------
        

        Healthcare Solutions Dashboard Output
        Brought to you by Rohan Duhaney
        Contact: 856-522-3601 | Email: [email protected] | Website: smartduhaney.com
        ----------------------------------------------------------------------
        Condition: Sickle Cell Disease|Diffuse Myocardial Fibrosis
        Cure: DRUG: Losartan

        For Investors only investing in a study:
        Financial Forecast:
        • Total Cost per Patient: $120,000.00
        • Total Revenue per Patient: $1,008,000.00
        • ROI: 740.0%

        NCT Number: NCT05012631
        Study Phase: PHASE2
        Study Status: RECRUITING

        Additional Insights:
        • Devices/Interventions: No device listed
        • Enrollment: 24
        • Sponsor: Children's Hospital Medical Center, Cincinnati
        ----------------------------------------------------------------------
        We HAVE UNLIMITED INFORMATION READY TO EXPLORE

Shipping Notes
  • Free Standard Shipping on $100+ Orders to the USA.
  • Except Preorder products are shipped in 48 hours.
  • Delivery to the USA:
  1. Standard Shipping : 3-10 business days
  • If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy
SKU: 88867085907

Discover Niche Categories That Outsell

Top-Converting Item to Boost Your Average Order

4.9 ★★★★★
Based on 893 reviews
Sort
Highest Rating
Newest First
Oldest First
Product Reviews
D
Verified Purchase
dallinna
Chelsea, US
★★★★★ 5
Great hit with my dog
Color: Grey, Color: Grey
The gray rhino is a great hit with my dog. She's a medium size golden (53lbs) likes to chew and tug, but she is not not too aggressive with toys, and this has become her favorite toy. Over the last 2 weeks she's removed the top arms from the body and "killed" one of the squeakers, and the arms are now a separate tug toy. We could have put the arms back, but she figured out those come off, and she would take them out again. The armless rhino is still the one she carries around from room to room, plating tug and fetch with every day. The toy is very well stitched, the fabric is of good quality and there are no small pieces that come apart to be swallowed. It gets dirty from all the playing so I plan to throw it in the wash every month or so.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 25, 2024
M
Verified Purchase
MiMi
Natrona Heights, US
★★★★★ 5
Love it!!!
Color: Grey
I have bought three of these for my French bulldog. She has went through three of them already. She loves this toy highly recommend for an energetic dog.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 6, 2026
M
Verified Purchase
MGman
Charlottesville, US
★★★★★ 5
Great toy
Color: Grey
My girl loves this toy. She has a lot of toys but this is her favorite. She is a 26 lb mini golden and we have had it over a year. It is just now starting to show wear. Once it is completely worn out I will buy it again!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 20, 2025
B
Verified Purchase
Brent Schloer
Dallas, US
★★★★★ 5
Durable product.
Color: Grey
My dog loves it. Very durable.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 12, 2026
E
Verified Purchase
EWF
Lexington, US
★★★★★ 1
15 Minutes….with update x2
Color: Orange
Within 15 minutes my 10-month old puppy had one of the moose antlers torn half off. I’ll see if he is able to destruct any more of this “indestructible” toy. If it holds up I’ll come back and upgrade the number of stars but for now…not impressed. UPDATE: Sadly he was able to rip it open via the appendages (the legs). The main body of the toy seems pretty tough but no dog is going to keep away from the legs. Downgrade to 1 star. UPDATE #2: I just received my second attempt at using this “indestructible” toy. This time I went with the rino since the legs are rope and not a sewn on leg. Well, in about 5 minutes my puppy had the horn torn and the horn provides direct access to the inside stuffing. As mentioned above, the legs are rope. The design was pretty smart in that both the front legs is one posted of rope going through a hole made in the stuffed toy. Same for the rear legs. This prevents the dog tearing them off and getting access to the stuffing. Sadly the horn being torn off right away makes this toy destructible. I think the only way they may be successful calling this an indestructible toy would be if they made a ball out of the body material or perhaps something in the shape of a bone.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on October 9, 2023

recommand products